Eric Pauwels's Net Worth
$6.12 Million
Who is Eric Pauwels?
Eric Pauwels has an estimated net worth of $6.12 Million. This is based on reported shares across multiple companies, which include PTC THERAPEUTICS, INC., ACCURAY INC, NPS PHARMACEUTICALS INC, and TRANSKARYOTIC THERAPIES INC.
SEC CIK
Eric Pauwels's CIK is 0001323212
Past Insider Trading and Trends
2014 was Eric Pauwels's most active year for acquiring shares with 7 total transactions. Eric Pauwels's most active month to acquire stocks was the month of January. 2015 was Eric Pauwels's most active year for disposing of shares, totalling 14 transactions. Eric Pauwels's most active month to dispose stocks was the month of January. 2020 saw Eric Pauwels paying a total of $2,374,500.00 for 60,000 shares, this is the most they've acquired in one year. In 2015 Eric Pauwels cashed out on 318,716 shares for a total of $1,639,284.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $31.54
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.15% | -787.00 |
$25.14 | -$19,781.25 | 67.69K |
Apr 17
| |||
Form 4
| +55.00% | 24.3K |
—
|
—
| 68.48K |
Feb 15
| |||
Form 4
| -0.82% | -366.00 |
$27.25 | -$9,973.79 | 44.18K |
Scheduled
|
Jan 30
| ||
Form 4
| -7.54% | -3.63K |
$28.85 | -$104,852.19 | 44.55K |
Scheduled
|
Jan 8 - Jan 9
| ||
Form 4
| -15.04% | -8.42K |
$58.97 | -$496,282.27 | 47.55K |
May 19 - May 22
| |||
Form 4
| -13.63% | -8.84K |
$58.52 | -$517,088.87 | 55.97K |
May 17 - May 18
| |||
Form 4
| -1.12% | -732.00 |
$52.04 | -$38,095.99 | 64.81K |
Apr 18
| |||
Form 4
| -0.57% | -375.00 |
$45.63 | -$17,110.50 | 65.54K |
Jan 31
| |||
Form 4
| -0.54% | -359.00 |
$47.45 | -$17,035.02 | 65.91K |
Jan 24
| |||
Form 4
| -1.83% | -1.23K |
$43.59 | -$53,793.84 | 66.27K |
Jan 10 - Jan 11
| |||
Form 4
| -1.26% | -858.00 |
$41.66 | -$35,741.02 | 67.5K |
Jan 9
| |||
Form 4
| +35.74% | 18K |
—
|
—
| 68.36K |
Jan 5
| |||
Form 4
| -1.62% | -822.00 |
$42.52 | -$34,947.33 | 49.77K |
Apr 19
| |||
Form 4
| -0.72% | -367.00 |
$40.00 | -$14,680.73 | 50.59K |
Feb 1
| |||
Form 4
| -0.70% | -359.00 |
$39.31 | -$14,113.73 | 50.96K |
Jan 25
| |||
Form 4
| +45.03% | 15.93K |
$38.53 | -$33,362.65 | 51.32K |
Jan 7
| |||
Form 4
| -2.23% | -806.00 |
$41.16 | -$33,176.57 | 35.39K |
Jan 4
| |||
Form 4
| -2.15% | -786.00 |
$48.17 | -$37,860.05 | 35.7K |
Apr 19
| |||
Form 4
| -0.98% | -362.00 |
$56.96 | -$20,618.07 | 36.49K |
Feb 1
| |||
Form 4
| -1.16% | -431.00 |
$62.05 | -$26,745.27 | 36.85K |
Jan 25
| |||
Form 4
| +37.67% | 10.2K |
—
|
—
| 37.28K |
Jan 6
| |||
Form 4
| -3.79% | -1.07K |
$62.37 | -$66,548.79 | 27.08K |
Jan 5
| |||
Form 4
| -18.30% | -6.19K |
$56.50 | -$349,961.00 | 27.65K |
Scheduled
|
Nov 3
| ||
Form 4
| +41.94% | 10K |
—
|
—
| 33.84K |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACCURAY INC (ARAY) Snapshot price: $1.92
SVP Chief Marketing Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NPS PHARMACEUTICALS INC No price found
President, NPS Pharma Int'l
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -30.03K |
$46.00 | -$1,381,334.00 |
0
|
Feb 21
| |||
Form 4
| +50.91% | 10.13K |
$45.87 | -$257,950.55 | 30.03K |
Feb 7 - Feb 13
| |||
Form 4
| +24.13% | 4.82K |
$27.55 | -$142,846.75 | 24.77K |
Sep 26
| |||
Form 4
| +3.62% | 1.05K |
$27.86 | -$17,273.20 | 29.95K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +22.31% | 5.27K |
$38.30 | -$108,312.40 | 28.9K |
Feb 12 - Feb 13
| |||
Form 4
| +15.14% | 3.11K |
$35.13 | -$61,793.67 | 23.63K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +14.88% | 2.94K |
$8.61 | -$16,608.69 | 22.67K |
Feb 7
| |||
Form 4
|
∞
| 14.6K |
—
|
—
| 14.6K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TRANSKARYOTIC THERAPIES INC No price found
Sr. VP- Global Commercial Ops
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||